AL HASSAN MEDICS LIMITED
Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | — | £16.5k |
| Current assets | — | £19.8k |
| Net assets | — | £16.5k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 2 officers
- • 2 persons-with-significant-control
- • 1 confirmation-statement
Corporate timeline (20 events)Click to expand
- 2026-04-02➕HASSAN, Syed Dawood appointeddirector
- 2026-04-02➖HASSAN, Syed Dawood resigneddirector
- 2026-04-02📄appoint-person-director-company-with-name-dateofficers · AP01
- 2026-04-02📄termination-director-company-with-name-termination-dateofficers · TM01
- 2026-04-02📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2026-04-02📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2025-12-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-12-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-12-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2021-12-27📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2020-12-18📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-12-13📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-12-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2018-04-19📄dissolution-withdrawal-application-strike-off-companydissolution · DS02
- 2018-03-06📄gazette-notice-voluntarygazette · GAZ1(A)
- 2018-02-22📄dissolution-application-strike-off-companydissolution · DS01
- 2017-12-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2013-03-08🏢Company incorporatedAs AL HASSAN MEDICS LIMITED
- 2013-03-08➕HASSAN, Syed Dawood appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder name in company name: Company name contains director surname "HASSAN" — strong identity link between founder and business.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Syed Dawood Hassan Individual · British · DOB 11/1981 · age 45 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 02/04/2026 |
1 historic (ceased) PSC
- Mr Syed Dawood Hassanceased 02/04/2026· 75-100% shares
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · N postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AHEARNE ORTHOPAEDICS LIMITED→ 10635333 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| AIE HEALTH LTD→ 14682658 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| AINARA SANDOVAL LTD→ 13267620 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| AIT MEDICAL LTD→ 15256434 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AJNA HEALTH LTD→ 10708611 · est 2017 · no financials extracted | — | — | — | — | 9y | — | — |
| AKHRIYA LIMITED→ 15298153 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AKTAS HEALTH LTD→ 11972582 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ALAN COLAM PSYCHOANALYST LIMITED→ 16230420 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ALCHEMY PERSONAL AND ORGANISATIONAL DEVELOPMENT LIMITED→ 05706364 · est 2006 · no financials extracted | — | — | — | — | 20y | — | — |
| ALCOHOL HEALTH NETWORK CIC→ 08090638 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| ALDANAT CARE SERVICES LTD→ 09432914 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| ALEKSANDRA DAHAI LTD→ 13383304 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 1 resigned)
Click a director name to see their full track record across all companies.